INTROVALE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Introvale, and when can generic versions of Introvale launch?
Introvale is a drug marketed by Xiromed and is included in one NDA.
The generic ingredient in INTROVALE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INTROVALE?
- What are the global sales for INTROVALE?
- What is Average Wholesale Price for INTROVALE?
Summary for INTROVALE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 277 |
| Drug Prices: | Drug price information for INTROVALE |
| DailyMed Link: | INTROVALE at DailyMed |
US Patents and Regulatory Information for INTROVALE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiromed | INTROVALE | ethinyl estradiol; levonorgestrel | TABLET;ORAL | 079064-001 | Sep 27, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
